Locust Wood Capital Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.2M Sell
1,174,983
-951,895
-45% -$62.6M 1.81% 23
2026
Q1
$151M Sell
2,126,878
-617
-0% -$48.7K 3.83% 11
2025
Q4
$174M Buy
2,127,495
+43,158
+2% +$3.36M 4.22% 6
2025
Q3
$157M Buy
2,084,337
+137,992
+7% +$10.3M 3.91% 9
2025
Q2
$144M Buy
1,946,345
+202,027
+12% +$14.1M 3.84% 7
2025
Q1
$141M Buy
1,744,318
+333,642
+24% +$28.7M 4.46% 8
2024
Q4
$110M Buy
1,410,676
+232,721
+20% +$19.8M 3.81% 9
2024
Q3
$111M Buy
1,177,955
+53,656
+5% +$4.5M 3.69% 10
2024
Q2
$87.6M Buy
1,124,299
+348,521
+45% +$28.4M 3.14% 15
2024
Q1
$70.5M Buy
775,778
+421,099
+119% +$35M 2.53% 18
2023
Q4
$27.4M Buy
+354,679
New +$24.8M 1.04% 30

Other funds holding GEHC

Locust Wood Capital Advisers's GEHC Position: Q2 2026 in Review

Locust Wood Capital Advisers reduced its GE HealthCare (GEHC) stake by 45% in Q2 2026, selling an estimated $62.6M and leaving 1,174,983 shares worth $75.2M. The position accounts for 1.81% of the portfolio, ranked #23.

Locust Wood Capital Advisers first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $174M in Q4 2025. 1,219 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Locust Wood Capital Advisers held 1,174,983 shares of GE HealthCare worth $75.2M as of Q2 2026.
  • Locust Wood Capital Advisers sold 951,895 GE HealthCare shares in Q2 2026, an estimated $62.6M.
  • GE HealthCare made up 1.81% of Locust Wood Capital Advisers's portfolio in Q2 2026, its #23 holding.
  • Locust Wood Capital Advisers first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • Locust Wood Capital Advisers's GE HealthCare position peaked at $174M in Q4 2025.
  • 1,219 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Locust Wood Capital Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.